Related Experiment Video
Updated: Mar 30, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Diagnosis and/or classification of vasculitis: different?
1aAcademic Hospital, Uskudar, Istanbul, Turkey bNYU Hospital for Joint Diseases, New York, USA.
Developing separate diagnostic and classification criteria for vasculitides is unrealistic. Probabilistic reasoning is crucial for accurate diagnosis and patient care, yet often overlooked in current research.
Area of Science:
- Rheumatology
- Clinical Immunology
Background:
- Current diagnostic criteria for vasculitides are lacking.
- Initiatives by the European League Against Rheumatism and American College of Rheumatology aim to establish separate classification and diagnostic criteria.
- This review re-evaluates previous disagreements regarding separate criteria in light of new evidence.
Purpose of the Study:
- To critically assess the feasibility and utility of developing separate diagnostic and classification criteria for vasculitides.
- To highlight the inadequate incorporation of probabilistic methods in existing criteria development.
Main Methods:
- Review of existing literature on diagnostic and classification criteria for vasculitides.
- Analysis of methodologies used in criteria development, focusing on the application of probability theory.
Main Results:
- No clear methodologies for separate diagnostic and classification criteria have been proposed.
- Probabilistic concepts like Bayes' theorem, predictive values, and confidence intervals are underutilized (less than 4% of reviewed articles).
- Persistent misconceptions regarding circularity and the role of nomenclature in criteria development were observed.
Conclusions:
- Separate diagnostic and classification criteria for vasculitides are deemed unrealistic and impractical.
- Classification criteria and nomenclature serve as tools for diagnosis, not distinct entities for patient care or research.
- Emphasizing a transparent discussion of diagnostic probabilities is essential for patients and all stakeholders.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiovascular Drugs: Classification based on Therapeutic Indications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Myocarditis II: Clinical Features and Diagnostic Tests

